Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection.
Mairi Ziaka, Sophia L Markantonis, Marizoza Fousteri, Paris Zygoulis, Dimitris Panidis, Marios Karvouniaris, Demosthenes Makris, Epaminondas Zakynthinos
Index: Antimicrob. Agents Chemother. 57(4) , 1938-40, (2013)
Full Text: HTML
Abstract
Colistin pharmacokinetics were prospectively studied after intravenous administration of colistin methanesulphonate in critically ill patients without central nervous system infection (controls, n = 5) and in patients with external ventricular drain-associated ventriculitis after intravenous administration (EVDViv, n = 3) or combined intravenous/intraventricular administration (EVDVcomb, n = 4). Cerebrospinal fluid (CSF)/serum colistin concentration ratios were higher in EVDViv than in control patients (11% versus 7%, P ≤ 0.05) and in EVDVcomb compared to all other patients (P < 0.0001). CSF colistin concentrations above the MIC of 0.5 μg/ml were achieved only in EVDVcomb patients.
Related Compounds
Related Articles:
2014-11-21
[J. Chromatogr. A. 1369 , 52-63, (2014)]
2015-01-01
[PLoS ONE 10 , e0142097, (2015)]
2001-03-01
[Antimicrob. Agents Chemother. 45 , 781-785, (2001)]
2012-09-01
[J. Pharm. Pharmacol. 64(9) , 1316-25, (2012)]
2012-06-01
[Clin. Infect. Dis. 54(12) , 1720-6, (2012)]